Drug development - NGS Sequencing

= Special COVID-19 = Coronavirus SARS-CoV2 Drug development - NGS Sequencing

Service description

Sequencing occurs at many stages of drug development. In the case of the COVID-19 epidemic, sequencing of the SARS-CoV2 virus that has infected patients may assess whether it has mutated or not, and patient sequencing may be relevant to determine particular resistance or susceptibility.

Materials to provide

Further details on the project may be requested directly by the expert. You will be able to exchange directly with the experts after filling in the form below.

Delivrable(s)

  • Study following the specifications validated with the Expert

Your project

Please answer all questions below to specify your requirements